Sign in

CIK 0001559053

  • Accelerated filer

PROTHENA CORP PUBLIC LTD CO

Sign in to watch
Ticker
PRTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Ireland
Entity type
Operating
Phone
+353 12362500
Business address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
Former names
Prothena Corp plc, Neotope Corp Ltd
Open-market buys, last 90 days
$9,848,721
in 10 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. SCULLY WILLIAM P +$9.8M 10% owner 10 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-28 Kinney Gene G. President and CEO Option exercise +84,000 152,793
2026-07-28 Kinney Gene G. President and CEO Returned to the company −84,000 $8.56 $719K 68,793
2026-07-28 Kinney Gene G. President and CEO Option exercise · Restricted Stock Units −84,000 0
2026-03-03 Kinney Gene G. President and CEO Grant or award · Stock Option (Right to Buy) +520,000 520,000
2025-07-28 Kinney Gene G. President and CEO Grant or award +140,000 152,793
2025-03-05 Kinney Gene G. President and CEO Grant or award · Stock Option (Right to Buy) +375,000 375,000
2024-02-27 Kinney Gene G. President and CEO Grant or award · Stock Option (Right to Buy) +307,000 307,000
2023-05-17 Kinney Gene G. President and CEO Option exercise 10b5-1 +45,000 $29.81 $1.3M 57,793
2023-05-17 Kinney Gene G. President and CEO Sale 10b5-1 −10,202 $72.70 $742K 47,591
2023-05-17 Kinney Gene G. President and CEO Sale 10b5-1 −19,864 $73.60 $1.5M 27,727
2023-05-17 Kinney Gene G. President and CEO Sale 10b5-1 −14,934 $74.49 $1.1M 12,793
2023-05-17 Kinney Gene G. President and CEO Option exercise · Stock Option (Right to Buy) 10b5-1 −45,000 0
2023-03-02 Kinney Gene G. President and CEO Grant or award · Stock Option (Right to Buy) +155,000 155,000
2022-09-28 Kinney Gene G. President and CEO Option exercise +16,412 $6.41 $105K 29,205
2022-09-28 Kinney Gene G. President and CEO Sale −1,045 $48.09 $50K 28,160
2022-09-28 Kinney Gene G. President and CEO Sale −128 $49.41 $6K 28,032
2022-09-28 Kinney Gene G. President and CEO Sale −552 $51.30 $28K 27,480
2022-09-28 Kinney Gene G. President and CEO Sale −2,333 $52.44 $122K 25,147
2022-09-28 Kinney Gene G. President and CEO Sale −5,852 $53.40 $312K 19,295
2022-09-28 Kinney Gene G. President and CEO Sale −4,748 $54.38 $258K 14,547

Page 1 of 3 · 51 trades